US 10800769
Heterocyclic inhibitors of ATR kinase
granted A61KA61K2300/00A61K45/06
Quick answer
US patent 10800769 (Heterocyclic inhibitors of ATR kinase) held by The Board of Regents of the University of Texas System expires Mon Oct 08 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Board of Regents of the University of Texas System
- Grant date
- Tue Oct 13 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 08 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 16
- CPC classes
- A61K, A61K2300/00, A61K45/06, A61P, A61P35/00